Functional characterization of variants improves cancer risk assessment and treatment

[News]

Findings from a multi-institutional, international study led by researchers from the Mayo Clinic Comprehensive Cancer Center have significantly advanced the understanding of genetic alterations in the BRCA2 gene, a key player in hereditary cancer risk.

More... (https://www.news-medical.net/news/20250109/Functional-characterization-of-variants-improves-cancer-risk-assessment-and-treatment.aspx)